Core Viewpoint - Momentum investing focuses on "buying high and selling higher," contrasting with traditional strategies of "buying low and selling high" [1] Group 1: Momentum Investing Strategy - Momentum investing can be risky as stocks may lose momentum if their valuations exceed future growth potential [1] - Identifying the right entry point for momentum stocks is challenging, leading to potential losses if the stock price does not continue to rise [1] Group 2: Bargain Momentum Stocks - Investing in bargain stocks that have recently shown price momentum may be a safer strategy [2] - The Zacks Momentum Style Score is useful for identifying strong momentum stocks, while the 'Fast-Paced Momentum at a Bargain' screen helps find attractively priced stocks [2] Group 3: Petco Health & Wellness (WOOF) - Petco Health & Wellness (WOOF) has a four-week price change of 16.6%, indicating strong recent price momentum [3] - WOOF has gained 5.6% over the past 12 weeks, demonstrating its ability to deliver positive returns over a longer timeframe [4] - The stock has a beta of 1.89, suggesting it moves 89% higher than the market in either direction, indicating fast-paced momentum [4] Group 4: Valuation and Earnings Estimates - WOOF has a Momentum Score of A, indicating a favorable time to invest [5] - The stock has a Zacks Rank 2 (Buy) due to upward revisions in earnings estimates, which attract more investor interest [6] - WOOF is trading at a Price-to-Sales ratio of 0.25, meaning investors pay 25 cents for each dollar of sales, indicating a reasonable valuation [6] Group 5: Additional Investment Opportunities - Besides WOOF, there are other stocks that meet the criteria of the 'Fast-Paced Momentum at a Bargain' screen, suggesting further investment opportunities [7] - Zacks offers over 45 Premium Screens tailored to different investing styles, aiding in stock selection [8]

Financial Performance - Net sales increased from $1.49 billion to $1.51 billion, representing a period-over-period increase of 1.2%[93] - Operating income improved to $4.0 million, compared to an operating loss of $1,232.1 million in the prior year, primarily due to goodwill impairment[93] - Adjusted EBITDA rose from $72.2 million to $81.2 million[93] - Comparable sales change was 1.8% for the thirteen weeks ended November 2, 2024, compared to 0.0% for the same period last year[96] - Total net sales for the thirty-nine weeks ended November 2, 2024, were $4.56 billion, slightly down from $4.58 billion in the prior year[94] - Gross profit margin improved to 38.1% for the thirteen weeks ended November 2, 2024, compared to 36.8% in the prior year[96] - Net sales increased by $17.3 million, or 1.2%, to $1.51 billion for the thirteen weeks ended November 2, 2024, compared to $1.49 billion for the same period last year[19] - Gross profit rose by $25.8 million, or 4.7%, to $575.8 million for the thirteen weeks ended November 2, 2024, with a gross profit rate of 38.1%[99] - The gross profit decreased by $12.3 million, or 0.7%, to $1,735.1 million for the thirty-nine weeks ended November 2, 2024[99] - Adjusted EBITDA for the thirty-nine weeks ended November 2, 2024, was $81.2 million, compared to $72.2 million for the same period in 2023, reflecting a 14% increase[111] - Net sales for the thirty-nine weeks ended November 2, 2024, were $1.51 billion, slightly up from $1.49 billion in the prior year, indicating a growth of approximately 1%[111] Loss and Expenses - Net loss attributable to Class A and B-1 common stockholders decreased to $16.7 million from $1,241.1 million in the prior year[93] - SG&A expenses increased by $12.2 million, or 2.2%, to $571.8 million for the thirteen weeks ended November 2, 2024, representing 37.8% of net sales[100] - Free Cash Flow for the thirty-nine weeks ended November 2, 2024, was $(9.4) million, compared to $(7.8) million for the same period in 2023, showing a decline in cash generation[114] - The company reported a net loss attributable to Class A and B-1 common stockholders of $16.7 million for the thirty-nine weeks ended November 2, 2024, compared to a net loss of $1.24 billion in the prior year[111] Cash Flow and Liquidity - As of November 2, 2024, the company's liquidity was $644.3 million, which includes cash and cash equivalents of $116.7 million and $527.6 million available on the ABL Revolving Credit Facility[116] - Net cash provided by operating activities decreased to $81.7 million for the thirty-nine weeks ended November 2, 2024, down from $168.7 million in the same period of 2023, primarily due to increased cash paid for inventory[118] - Net cash used in investing activities was $89.5 million for the thirty-nine weeks ended November 2, 2024, a decrease from $156.1 million in the prior year, reflecting reduced capital expenditures[121] Debt and Interest - The company amended its ABL Revolving Credit Facility in March 2024, increasing total availability from $500 million to $581 million[125] - Interest on the ABL Revolving Credit Facility is now based on either the base rate with a 1% floor or Term SOFR with a 0% floor, plus an applicable margin[126] - The company repaid $75 million in principal on the First Lien Term Loan during the thirty-nine weeks ended October 28, 2023, using existing cash on hand[126] - As of November 2, 2024, the company had $1,595.3 million outstanding under the First Lien Term Loan, with no amounts outstanding under the ABL Revolving Credit Facility[140] - An increase of 100 basis points in variable rates on the First Lien Term Loan and ABL Revolving Credit Facility would increase annual cash interest by approximately $16.2 million[140] Market Conditions and Challenges - The company continues to face macroeconomic challenges, including rising interest rates and inflationary pressures, impacting discretionary item sales[86] - The decrease in supplies and companion animals sales was driven by a softening in discretionary spending due to the current macroeconomic environment[19] Strategic Initiatives - The company aims to enhance customer retention and increase basket size to improve comparable sales[89] - Service-related sales increased by 8.6% and 9.7% for the thirteen and thirty-nine week periods ended November 2, 2024, respectively[98] Accounting and Valuation - The company recorded a pre-tax goodwill impairment charge of $1.22 billion in the thirteen weeks ended October 28, 2023[101] - The company considers the Petco trade name as an indefinite-lived intangible asset, performing annual impairment tests during the fourth quarter[134] - Significant assumptions in determining the fair value of the trade name include prospective financial information, growth rates, and discount rates[135] - The company does not enter into forward currency contracts to hedge foreign currency exposure, with a hypothetical 10% change in exchange rates not expected to materially affect operating results[143] - Cash and cash equivalents as of November 2, 2024, were maintained at major financial institutions, likely exceeding insured limits, with minimal credit risk[142] - The company has the option to perform qualitative assessments for goodwill impairment testing, which may bypass quantitative assessments if fair value exceeds carrying value[132] - Management estimates of cash flow projections are used in quantitative assessments for goodwill impairment, which are subject to uncertainty[133] - There have been no material changes to critical accounting policies and estimates compared to those described in the 2023 Form 10-K[135]

Financial Data and Key Metrics Changes - Revenue for Q3 2024 was $1.51 billion, up 1% year-over-year, with comparable sales increasing by 2% year-over-year [30] - Gross margin expanded by 130 basis points to 38.1%, driven by product cost management and improvements in services margin [7][32] - Adjusted EBITDA was $81.2 million, with an adjusted EBITDA margin of 5.4%, up almost 60 basis points year-over-year [33] - Free cash flow was negative $10 million, showing a meaningful improvement year-over-year [35] Business Line Data and Key Metrics Changes - Consumables revenue grew by 3%, while supplies in companion animals declined by 3%, though this was an improvement of roughly 200 basis points sequentially [30] - Services revenue increased by 9%, driven by strength in vet hospitals and mobile clinics [18][31] - The gross profit was $576 million, up 5% from the prior year [32] Market Data and Key Metrics Changes - The overall market for pet supplies remains flat, with Petco focusing on self-help strategies to improve its business without relying on market growth [54] - Petco Mexico continues to be a market leader in pet specialty in Mexico, driving long-term profitable growth [37] Company Strategy and Development Direction - The company is focusing on three critical areas: merchandising, customer service, and operational efficiency [11] - Initiatives include optimizing product assortments, improving customer service standards, and enhancing supply chain efficiencies [20][21] - The hiring of key executives aims to strengthen leadership and drive revenue growth [24][25] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's trajectory and the potential for long-term sustainable profitable growth [26][27] - The company is encouraged by structural improvements and expects a solid finish to 2024, building momentum into 2025 [39] Other Important Information - The company is implementing stronger pricing strategies and has established processes for promotional assessments [14] - Management is actively engaging with vendors to improve relationships and optimize product offerings [12][98] Q&A Session Summary Question: Target same-store sales figure for leveraging cost base - Management emphasized the focus on permanent cost reductions and indicated that specific targets would be discussed in March [44][46] Question: Insights on supplies and companion animals segment - Management noted a sequential improvement in discretionary spending and highlighted the importance of innovation and customer engagement [50][52] Question: Pricing impact in the quarter - Management stated that the overall pricing environment has been rational, with no significant negative impacts [58] Question: Services margin improvement drivers - The improvement was attributed to cost actions and the maturation of vet hospitals, along with strength in the mobile services business [61][62] Question: Opportunities for savings and reinvestment - Management indicated that current cost reductions are permanent and not intended for reinvestment at this stage [67][68] Question: Holiday performance outlook - Management expressed optimism about the start of the quarter and noted sequential improvement from Q3 [71] Question: Regaining market share in 2025 - Management is optimistic about the company's potential for growth and the enthusiasm of associates in driving the turnaround [73] Question: Efficiency enhancements in vet hospitals - Management highlighted progress in profitability and staffing improvements in vet hospitals, with continued growth expected [76][80] Question: Glide path of gross margin improvement - Management refrained from providing specific guidance but expressed encouragement regarding ongoing improvements [84] Question: Contextualizing the decline in services in companion animals - Management reiterated that they are actively taking actions to improve performance in this category regardless of market conditions [88][89]

Company Performance - Petco Health & Wellness reported a quarterly loss of $0.02 per share, which was better than the Zacks Consensus Estimate of a loss of $0.03, and an improvement from a loss of $0.05 per share a year ago, indicating an earnings surprise of 33.33% [1] - The company posted revenues of $1.51 billion for the quarter ended October 2024, surpassing the Zacks Consensus Estimate by 0.92% and showing an increase from $1.49 billion in the same quarter last year [2] - Over the last four quarters, Petco has exceeded consensus EPS estimates two times and topped consensus revenue estimates three times [2] Stock Performance - Petco shares have increased approximately 59.8% since the beginning of the year, significantly outperforming the S&P 500's gain of 27.6% [4] - The current consensus EPS estimate for the upcoming quarter is $0.03 on revenues of $1.58 billion, while for the current fiscal year, the estimate is -$0.06 on revenues of $6.13 billion [8] Industry Outlook - The Zacks Industry Rank indicates that the Retail - Miscellaneous sector, to which Petco belongs, is currently in the bottom 30% of over 250 Zacks industries, suggesting potential challenges ahead [9] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact Petco's stock performance [6]

[Executive Summary & Q3 2024 Performance](index=1&type=section&id=Executive%20Summary%20%26%20Q3%202024%20Performance) Petco reported a 1.2% year-over-year increase in net revenue and improved GAAP net loss for Q3 2024, with the CEO emphasizing progress towards sustainable, profitable growth [Q3 2024 Financial Highlights](index=1&type=section&id=Q3%202024%20Financial%20Highlights) Petco reported a 1.2% year-over-year increase in net revenue to $1.51 billion and a 4.7% year-over-year increase in gross profit to $575.8 million for Q3 2024, with GAAP net loss significantly improving to $16.7 million from $1.2 billion in the prior year, which included a substantial non-cash goodwill impairment charge, and Adjusted EBITDA also saw an increase to $81.2 million Q3 2024 Key Financials (YoY Change) | Metric | Q3 2024 (Millions) | Q3 2023 (Millions) | Change (%) | | :---------------- | :----------------- | :----------------- | :--------- | | Net Revenue | $1,510 | $1,490 | 1.2% | | Gross Profit | $575.8 | $550.0 | 4.7% | | GAAP Net Loss | $(16.7) | $(1,200) | (98.6%) | | Adjusted Net Income | $(6.5) | $(14.5) | (55.2%) | | Adjusted EBITDA | $81.2 | $72.2 | 12.5% | - Consumables business was up **2.7% year-over-year**, and services and other business was up **5.0% year-over-year**, with this growth offset by a **2.8% year-over-year decline** in the supplies and companion animal business[3](index=3&type=chunk) [CEO Commentary](index=1&type=section&id=CEO%20Commentary) Petco's CEO, Joel Anderson, emphasized the meaningful progress in strengthening retail fundamentals to drive sustainable, profitable growth, expressing confidence in the company's strategic path and the organization's focus on profitability and free cash flow for a solid finish to 2024 - The company is making meaningful progress to strengthen retail fundamentals to drive sustainable, profitable growth[4](index=4&type=chunk) - The entire organization is focused on driving profitability and free cash flow[4](index=4&type=chunk) [Business Outlook](index=2&type=section&id=Business%20Outlook) Petco provides financial guidance for Fiscal Q4 2024 and the full fiscal year, detailing projections for net revenue, Adjusted EBITDA, EPS, net interest expense, and capital expenditures [Fiscal Q4 2024 Guidance](index=2&type=section&id=Fiscal%20Q4%202024%20Guidance) Petco provided specific guidance for Fiscal Q4 2024, projecting net revenue of approximately $1.55 billion, Adjusted EBITDA between $90 million and $95 million (including $10 million in third-party consulting fees), and Adjusted EPS between $0.00 and $0.02 Fiscal Q4 2024 Guidance | Metric | FQ4 2024 Guidance | | :---------------- | :----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | | Net Revenue | ~$1.55 billion | | Adjusted EBITDA | Between $90 million and $95 million (including a minimum of $10 million in third-party consulting fees associated with transformation effort) | | Adjusted EPS | Between $0.00 and $0.02 | [Fiscal 2024 Full Year Guidance](index=2&type=section&id=Fiscal%202024%20Full%20Year%20Guidance) For the full fiscal year 2024 (a 52-week year), Petco expects net interest expense to be approximately $140 million and capital expenditures to be around $130 million, assuming consistent economic conditions, currency rates, and tax/regulatory landscape, with a 26% tax rate and 273 million weighted average diluted shares Fiscal 2024 Full Year Guidance | Metric | 2024 Guidance | | :----------------- | :-------------- | | Net interest expense | ~$140 million | | Capital Expenditures | ~$130 million | - Assumptions for guidance include consistent economic conditions, currency rates, and tax/regulatory landscape, with a **26% tax rate** and **273 million weighted average diluted share count**[7](index=7&type=chunk) [Company Information](index=2&type=section&id=Company%20Information) This section introduces Petco's business operations, including its extensive pet care center network and wellness offerings, alongside a cautionary overview of forward-looking statements and key risk factors [About Petco](index=2&type=section&id=About%20Petco) Founded in 1965, Petco Health and Wellness Company, Inc. is a category-defining health and wellness company dedicated to improving the lives of pets, pet parents, and its partners, operating over 1,500 pet care centers across the U.S., Mexico, and Puerto Rico, offering a comprehensive ecosystem of merchandise, services (grooming, training, veterinary), and solutions, both in-store and digitally, and through Petco Love, the company supports animal welfare groups and has facilitated nearly 7 million animal adoptions - Petco operates more than **1,500 pet care centers** across the U.S., Mexico, and Puerto Rico[9](index=9&type=chunk) - The company offers comprehensive pet wellness products, services (grooming, training, on-site veterinary hospitals, mobile veterinary clinics), and solutions[9](index=9&type=chunk) - Through Petco Love, it has helped find homes for nearly **7 million animals** via in-store adoption events[11](index=11&type=chunk) [Forward-Looking Statements & Risk Factors](index=3&type=section&id=Forward-Looking%20Statements%20%26%20Risk%20Factors) This section serves as a cautionary statement regarding forward-looking information, highlighting that such statements are subject to significant uncertainties and contingencies, and outlines various risk factors that could cause actual results to differ materially from expectations, including increased competition, reduced consumer demand, reliance on key vendors, macroeconomic pressures (inflation, interest rates), and operational challenges - Forward-looking statements are based on current expectations and assumptions about future events that are subject to significant uncertainties and contingencies, many of which are outside the control of Petco[12](index=12&type=chunk) - Key risks include increased competition, reduced consumer demand, reliance on key vendors, macroeconomic pressures (inflation, interest rates, tariffs), failure to effectively manage costs, and supply chain issues[12](index=12&type=chunk) [Financial Statements](index=4&type=section&id=Financial%20Statements) This section presents Petco's consolidated financial statements, including detailed reports on operations, balance sheet positions, and cash flows for the specified periods [Consolidated Statements of Operations](index=4&type=section&id=Consolidated%20Statements%20of%20Operations) For the 13 weeks ended November 2, 2024, Petco reported total net sales of $1,511.4 million, a 1% increase year-over-year, with gross profit rising 5% to $575.8 million, and the company recorded a net loss of $16.7 million, a significant improvement from the $1,241.1 million net loss in the prior year, which included a substantial goodwill impairment charge Consolidated Statements of Operations (13 Weeks Ended) | Metric (in thousands) | Nov 2, 2024 | Oct 28, 2023 | Percent Change | | :------------------------------------------ | :---------- | :----------- | :------------- | | Total net sales | $1,511,437 | $1,494,166 | 1% | | Total cost of sales | $935,680 | $944,165 | (1%) | | Gross profit | $575,757 | $550,001 | 5% | | Selling, general and administrative expenses | $571,780 | $559,611 | 2% | | Goodwill impairment | — | $1,222,524 | (100%) | | Operating income (loss) | $3,977 | $(1,232,134) | N/M | | Net loss attributable to Class A and B-1 common stockholders | $(16,673) | $(1,241,137) | (99%) | | Net loss per Class A and B-1 common share (Diluted) | $(0.06) | $(4.63) | (99%) | [Consolidated Balance Sheets](index=5&type=section&id=Consolidated%20Balance%20Sheets) As of November 2, 2024, Petco's total assets were $5,211.5 million, a decrease from $5,363.2 million at February 3, 2024, with total liabilities also decreasing to $4,088.6 million from $4,178.7 million, while total stockholders' equity stood at $1,122.8 million Consolidated Balance Sheets (in thousands) | Metric | Nov 2, 2024 | Feb 3, 2024 | | :----------------------------------- | :---------- | :---------- | | Total current assets | $931,783 | $951,744 | | Fixed assets, net | $739,806 | $816,367 | | Goodwill | $980,064 | $980,297 | | Total assets | $5,211,480 | $5,363,152 | | Total current liabilities | $1,113,679 | $1,113,143 | | Total liabilities | $4,088,642 | $4,178,723 | | Total stockholders' equity | $1,122,838 | $1,184,429 | [Consolidated Statements of Cash Flows](index=6&type=section&id=Consolidated%20Statements%20of%20Cash%20Flows) For the 39 weeks ended November 2, 2024, net cash provided by operating activities was $81.7 million, a decrease from $168.7 million in the prior year, with net cash used in investing activities at $89.5 million and net cash used in financing activities at $7.8 million, resulting in a net decrease in cash, cash equivalents, and restricted cash of $15.6 million Consolidated Statements of Cash Flows (39 Weeks Ended, in thousands) | Metric | Nov 2, 2024 | Oct 28, 2023 | | :------------------------------------------ | :---------- | :----------- | | Net cash provided by operating activities | $81,680 | $168,696 | | Net cash used in investing activities | $(89,506) | $(156,149) | | Net cash used in financing activities | $(7,802) | $(84,040) | | Net decrease in cash, cash equivalents and restricted cash | $(15,628) | $(71,493) | | Cash, cash equivalents and restricted cash at end of period | $121,021 | $142,234 | [Non-GAAP Financial Measures](index=7&type=section&id=Non-GAAP%20Financial%20Measures) This section defines and reconciles Petco's non-GAAP financial measures, including Adjusted EBITDA, Adjusted Net Income, Adjusted EPS, and Free Cash Flow, to their GAAP equivalents, with detailed footnotes [Overview of Non-GAAP Measures](index=7&type=section&id=Overview%20of%20Non-GAAP%20Measures) This section provides definitions and reconciliations of non-GAAP financial measures, including Adjusted EBITDA, Adjusted Net Income, Adjusted EPS, and Free Cash Flow, to their most directly comparable GAAP measures, as management uses these non-GAAP metrics to offer investors a clearer view of Petco's core operating and earnings performance, facilitating period-over-period comparisons - Non-GAAP financial measures are provided as supplemental information and should not be considered superior to, or a substitute for, GAAP measures[22](index=22&type=chunk) - Management believes Adjusted EBITDA, Adjusted Net Income, and Adjusted EPS are meaningful for investors to compare current and prior period performance and assess core operating performance[24](index=24&type=chunk)[28](index=28&type=chunk) [Adjusted EBITDA Reconciliation](index=7&type=section&id=Adjusted%20EBITDA%20Reconciliation) Adjusted EBITDA for the 13 weeks ended November 2, 2024, increased to $81.2 million from $72.2 million in the prior year, with the trailing twelve-month Adjusted EBITDA at $345.7 million as of November 2, 2024, and an Adjusted EBITDA Margin of 5.5% Reconciliation of Net Loss to Adjusted EBITDA (13 Weeks Ended) | Metric (in thousands) | Nov 2, 2024 | Oct 28, 2023 | | :----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | :---------- | :----------- | | Net loss attributable to Class A and B-1 common stockholders | $(16,673) | $(1,241,137) | | Interest expense, net | $34,451 | $35,418 | | Income tax benefit | $(857) | $(22,902) | | Depreciation and amortization | $50,109 | $50,674 | | Goodwill impairment | — | $1,222,524 | | Adjusted EBITDA | $81,236 | $72,159 | Reconciliation of Net Loss to Adjusted EBITDA (Trailing Twelve Months) | Metric (in thousands) | Nov 2, 2024 | Feb 3, 2024 | Oct 28, 2023 | | :-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | :---------- | :---------- | :----------- | | Net loss attributable to Class A and B-1 common stockholders | $(110,554) | $(1,280,210) | $(1,224,903) | | Adjusted EBITDA | $345,743 | $401,103 | $453,652 | | Adjusted EBITDA Margin | 5.5% | 6.4% | 7.4% | [Adjusted Net Income and Adjusted EPS Reconciliation](index=8&type=section&id=Adjusted%20Net%20Income%20and%20Adjusted%20EPS%20Reconciliation) Adjusted Net Loss for the 13 weeks ended November 2, 2024, was $(6.5) million, or $(0.02) per share, showing an improvement from $(14.5) million, or $(0.05) per share, in the prior year, with this reconciliation adjusting for items such as goodwill impairment, equity-based compensation, and other non-operating income, applying a 26% normalized tax rate Reconciliation of Diluted EPS to Adjusted EPS (13 Weeks Ended) | Metric (in thousands, except per share) | Nov 2, 2024 Amount | Nov 2, 2024 Per share | Oct 28, 2023 Amount | Oct 28, 2023 Per share | | :---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | :----------------- | :-------------------- | :------------------ | :--------------------- | | Net loss attributable to common stockholders / diluted EPS | $(16,673) | $(0.06) | $(1,241,137) | $(4.63) | | Goodwill impairment | — | — | $1,222,524 | $4.57 | | Equity-based compensation | $11,357 | $0.04 | $18,183 | $0.07 | | Adjusted Net Loss / Adjusted EPS | $(6,533) | $(0.02) | $(14,466) | $(0.05) | [Free Cash Flow Reconciliation](index=9&type=section&id=Free%20Cash%20Flow%20Reconciliation) Free Cash Flow for the 13 weeks ended November 2, 2024, was $(10.3) million, an improvement from $(28.1) million in the prior year, and for the 39 weeks ended November 2, 2024, Free Cash Flow was $(9.4) million, compared to $(7.8) million in the prior year Free Cash Flow (in thousands) | Metric | 13 Weeks Ended Nov 2, 2024 | 13 Weeks Ended Oct 28, 2023 | 39 Weeks Ended Nov 2, 2024 | 39 Weeks Ended Oct 28, 2023 | | :------------------------------------------ | :------------------------- | :-------------------------- | :------------------------- | :-------------------------- | | Net cash provided by operating activities | $20,724 | $34,431 | $81,680 | $168,696 | | Cash paid for fixed assets | $(31,012) | $(62,509) | $(91,041) | $(176,532) | | Free Cash Flow | $(10,288) | $(28,078) | $(9,361) | $(7,836) | [Non-GAAP Financial Measures Footnotes](index=9&type=section&id=Non-GAAP%20Financial%20Measures%20Footnotes) This section provides detailed explanations for specific adjustments made in the non-GAAP calculations, clarifying that Mexico Joint Venture EBITDA represents 50% of the entity's operating results, adjusted for consistency, and defines acquisition and divestiture-related costs as direct costs from such activities, with 'other costs' including restructuring, legal reserves for significant non-ordinary matters, and strategic transaction costs, additionally defining net margin and Adjusted EBITDA margin - Mexico Joint Venture EBITDA is **50% of the entity's operating results**, adjusted to reflect a basis comparable to Adjusted EBITDA[34](index=34&type=chunk) - Acquisition and divestiture-related costs include direct costs such as third-party professional and legal fees, losses on sales of divestitures, and other integration-related costs[35](index=35&type=chunk) - Other costs include restructuring costs, restructuring-related severance costs, legal reserves for significant non-ordinary course matters, and costs related to certain significant strategic transactions[35](index=35&type=chunk)

Q3 2024 Overview Net revenue of $1.51 billion increased 1.2 percent year over year and comparable sales increased 1.8 percent year over year Gross profit of $575.8 million increased 4.7 percent year over year, compared to $550.0 million in the prior year GAAP net loss of $16.7 million, or $(0.06) per share, compared to GAAP net loss of $1.2 billion, or $(4.63) per share in the prior year that included a $1.2 billion non-cash goodwill impairment charge Adjusted Net Income1 of $(6.5) million, or $(0.02) per ...

Core Insights - Petco Health and Wellness Company, Inc. has appointed Joe Venezia as Chief Revenue Officer, effective November 17, 2024, reporting to CEO Joel Anderson [1][2] - Venezia will focus on driving revenue and enhancing customer experience through integrated strategies across various critical areas [1][3] Company Overview - Petco, founded in 1965, is a health and wellness company dedicated to improving the lives of pets and their owners, operating over 1,500 pet care centers across the U.S., Mexico, and Puerto Rico [4] - The company offers a wide range of services including merchandise, grooming, training, and veterinary services, and has a strong commitment to animal welfare through partnerships with local organizations [4] Leadership Background - Joe Venezia brings over 25 years of retail experience, previously serving as Chief Operating Officer of Stores at Michaels, and has held leadership roles at Bridgestone Retail Operations, Toys "R" Us, Walmart, and Procter & Gamble [3]

Core Viewpoint - The article emphasizes the importance of value investing and highlights Petco Health and Wellness Co. (WOOF) as a strong value stock based on its financial metrics and Zacks Rank [1][2][6] Group 1: Value Investing - Value investing is a preferred strategy for identifying strong stocks across various market conditions, utilizing established valuation metrics [2] - The Zacks Rank and Style Scores system can help investors find stocks with specific traits, particularly in the "Value" category [3] Group 2: Petco Health and Wellness Co. (WOOF) - WOOF currently holds a Zacks Rank of 2 (Buy) and an A for Value, indicating strong potential as a value stock [3] - The company has a Price-to-Sales (P/S) ratio of 0.23, significantly lower than the industry average of 0.65, suggesting it may be undervalued [4] - WOOF's Price-to-Cash Flow (P/CF) ratio is 12.75, which is attractive compared to the industry's average of 19.17, indicating a favorable cash outlook [5] - Over the past 12 months, WOOF's P/CF has fluctuated between 2.74 and 16.65, with a median of 5.15, further supporting its undervaluation [5] - The combination of these metrics and a strong earnings outlook positions WOOF as an impressive value stock at present [6]

SAN DIEGO, Nov. 6, 2024 /PRNewswire/ -- On December 5, 2024, at approximately 4:00 p.m. Eastern, Petco Health and Wellness Company, Inc. (Nasdaq: WOOF), a complete partner in pet health and wellness, will release its third quarter 2024 earnings results.Additionally, Petco executives will host a conference call at approximately 4:30 p.m. Eastern to review the company's financial and operating performance.The call will be webcast live and the earnings release and presentation will be available on the company' ...

Core Viewpoint - Momentum investing focuses on "buying high and selling higher," contrasting with traditional strategies of "buying low and selling high" [1] Group 1: Momentum Investing Strategy - Momentum investing is characterized by a preference for fast-moving stocks rather than undervalued ones [1] - Investors face challenges in determining the right entry points, as stocks may lose momentum if their valuations exceed future growth potential [1] Group 2: Petco Health & Wellness (WOOF) Analysis - Petco Health & Wellness (WOOF) has shown a price increase of 6.8% over the past four weeks, indicating growing investor interest [2] - Over the past 12 weeks, WOOF's stock has gained 43%, demonstrating its ability to deliver positive returns over a longer timeframe [2] - WOOF has a beta of 1.92, suggesting it moves 92% higher than the market in either direction, indicating fast-paced momentum [3] Group 3: Valuation and Earnings Estimates - WOOF has a Momentum Score of B, suggesting it is an opportune time to invest in the stock [3] - The stock has a Zacks Rank 2 (Buy), supported by an upward trend in earnings estimate revisions, which attracts more investor interest [3] - WOOF is trading at a Price-to-Sales ratio of 0.24, indicating it is relatively cheap, as investors pay only 24 cents for each dollar of sales [3] Group 4: Additional Investment Opportunities - Besides WOOF, there are other stocks that meet the criteria of the 'Fast-Paced Momentum at a Bargain' screen, presenting further investment opportunities [4] - The Zacks Premium Screens offer over 45 strategically created options to help identify potential winning stocks [4]